Ipsen announces partnership with Day One Biopharmaceuticals to bring tovorafenib to children living with pediatric low-grade glioma outside of the U.S. #leamanlifesciences https://lnkd.in/ewhmUbBM
Leaman Life Sciences
Staffing and Recruiting
London, England 46,212 followers
Making hiring simple for the Pharmaceutical, Biotechnology and CRO industries.
About us
At Leaman Life Sciences, we are dedicated to streamlining the job search and recruitment process for both candidates and clients in the life sciences industry. Our team is comprised of experienced, highly trained, and professional talent acquisition personnel, who are committed to providing a personalized service with a focus on quality over quantity. We pride ourselves on our partnerships with leading pharmaceutical, biopharmaceutical, and CRO companies in the hiring of highly skilled life sciences professionals globally. Our philosophy of prioritizing the personal touch and simplifying complex talent acquisition processes sets us apart in an industry where stress and tension can be commonplace. If you are open to a confidential conversation, please reach out to the following person(s): E: info@leamanlifesciences.com T: +44(020) 3815 3490
- Website
-
http://www.leamanlifesciences.com/
External link for Leaman Life Sciences
- Industry
- Staffing and Recruiting
- Company size
- 11-50 employees
- Headquarters
- London, England
- Type
- Public Company
- Founded
- 2015
- Specialties
- Staffing and Recruiting, Clinical Development, Pharmaceutical, Biotechnology, CRO, Medical Device, Medical Affairs, Clinical Operations, Commercial and Marketing, Pharmacology, Regulatory Affairs, Contract Staffing, Permanent Staffing, Talent Acquisition, Market Access & HEOR, and Life Sciences
Locations
-
Primary
47 Marylebone Lane
London, England W1U 2NT, GB
-
37 WEST 57TH STREET FLOOR 5
MANHATTAN, New York 10019, US
Employees at Leaman Life Sciences
-
Alexander Coltman
Connecting Life Science professionals with fulfilling opportunities
-
Joseph Corderoy
Business Development and Sales Lead at Leaman Life Sciences
-
Callum Costello
Finding the 'Needle in the Chaystack' talent
-
Joe Beddows
Senior Manager - Recruitment Delivery at Leaman Life Sciences
Updates
-
THIRD ARC BIO have successfully launched with an Oversubscribed $165 Million Series A Financing to Deliver Superior Biologics for Solid Tumors, Inflammatory & Immunology Diseases. They were launched in 2022 with seed financing from Omega Funds & have since advanced multiple programs that will enter the clinic starting in early 2025! Congratulations to Peter Lebowitz and Co ! #leamanlifesciences https://lnkd.in/eaJ-TAFK
Third Arc Bio Launches with Oversubscribed $165 Million Series A Financing to Deliver Superior Biologics for Solid Tumors and Inflammatory & Immunology (I&I) Diseases
prnewswire.com
-
Eli Lilly and Company to Acquire Morphic Therapeutic's to Improve Outcomes for Patients with Inflammatory Bowel Disease! #leamanlifesciences https://lnkd.in/dqjx6JTb
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease | Eli Lilly and Company
investor.lilly.com
-
Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development! #leamanlifesciences https://lnkd.in/eMt3TdmR
Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development
morningstar.com
-
Happy 4th July to all of our American friends, colleagues, clients, and family from everyone here at Leaman Life Sciences! #leamanlifesciences
-
-
Eli Lilly and Company's Alzheimer's drug Kisunla, a challenger to Biogen and Eisai US's Leqembi, gains full FDA approval ! #leamanlifesciences https://lnkd.in/e3Gmb7Bd
Game on: Lilly's Alzheimer's drug Kisunla, a challenger to Biogen and Eisai's Leqembi, gains full FDA nod
fiercepharma.com
-
Samsung Biologics announced Tuesday it has signed its largest contract ever—a $1.06 billion manufacturing deal with an unnamed pharmaceutical company headquartered in the U.S. ! #leamanlifesciences https://hubs.li/Q02F2jtp0
Samsung Bio Nabs $1B Manufacturing Contract With Undisclosed US Pharma | BioSpace
biospace.com
-
N-Power Medicine, Inc. Emerges with Series B Funding to Bolster Access to Innovative Oncology Clinical Trials! Congratulations Christer Svedman MD PhD and Co ! #leamanlifesciences https://lnkd.in/e-e5uTcC
N-Power Medicine Emerges with Series B Funding to Bolster Access to Innovative Oncology Clinical Trials | BioSpace
biospace.com
-
Eli Lilly and Company continues to strengthen its foothold in radiopharmaceuticals with a $140M upfront and $1B biobucks deal to partner with Radionetics Oncology on its pipeline of GPCR targeted drugs! #leamanlifesciences https://lnkd.in/gnxkk4eE
Lilly signs $140M upfront partnership with Radionetics in latest radiopharma play
fiercebiotech.com
-
Novo Nordisk to invest $4B into a North Carolina manufacturing plant to expand production of its fast-selling weight loss and diabetes drugs Wegovy and Ozempic! #leamanlifesciences https://lnkd.in/gKUSgXrZ
Novo to spend $4B on US plant, adding to obesity drug production push
biopharmadive.com